12 Health Care Stocks Moving In Friday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Friday's after-market session, several healthcare stocks experienced significant movements. Palisade Bio (PALI) saw a 66% increase, while Aptorum Gr (APM) rose by 18.88%. NovaBay Pharmaceuticals (NBY), MyMD Pharmaceuticals (MYMD), NuCana (NCNA), and Asensus Surgical (ASXC) also posted gains. Conversely, Acutus Medical (AFIB), Aclarion (ACON), Inspire Veterinary (IVP), HeartBeam (BEAT), Panbela Therapeutics (PBLA), and AquaBounty Techs (AQB) experienced declines.
January 26, 2024 | 9:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Acutus Medical shares declined by 9.4% to $0.21, with a market cap of $6.1 million.
A 9.4% drop in AFIB's stock price suggests negative market sentiment or disappointing news, which may lead to additional short-term selling pressure.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
AquaBounty Techs shares fell by 4.86% to $2.35, with a market cap of $9.0 million.
The decline of 4.86% in AQB's stock price may reflect investor uncertainty or negative developments, potentially leading to further short-term downside.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100
POSITIVE IMPACT
Aptorum Gr stock rose by 18.88% to $2.14, with a market cap of $11.0 million.
The 18.88% increase in APM's stock price indicates investor confidence, which may result in continued short-term appreciation.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Palisade Bio shares surged by 66% to $0.87, with a market cap of $8.0 million.
A significant after-market increase of 66% in PALI's stock price suggests strong investor interest, potentially due to positive news or expectations, which could lead to continued short-term upward momentum.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100